Viasat
VSAT
137 hedge funds and large institutions have $2.56B invested in Viasat in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 52 reducing their positions, and 22 closing their positions.
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
2% more capital invested
Capital invested by funds: $2.51B → $2.56B (+$48.6M)
6% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 52
5% less funds holding
Funds holding: 144 → 137 (-7)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
71% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $4.31M
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$13.6M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$7.33M |
| 3 |
Two Sigma Investments
New York
|
-$5.82M |
| 4 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
-$5.75M |
| 5 |
Two Sigma Advisers
New York
|
-$3.93M |
VSAT Hedge Fund Activity: Q2 2015 in Review
137 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Viasat (VSAT) for Q2 2015, worth a combined $2.56B — up 1.9% from $2.51B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of VSAT and 16 opened new positions — a net loss of 6 holders — while 52 trimmed existing stakes and 49 added.
The largest buyer was New South Capital Management, adding an estimated $21.3M. The largest seller was Millennium Management, cutting an estimated $13.6M.
- 137 institutional investors held Viasat (VSAT) as of Q2 2015, down from 144 in Q1 2015.
- Funds reported $2.56B of Viasat stock for Q2 2015, up 1.9% quarter-over-quarter.
- 16 funds opened new Viasat positions in Q2 2015 and 22 closed out, a net change of -6 holders.
- The largest Viasat buyer in Q2 2015 was New South Capital Management, an estimated $21.3M added.
- The largest Viasat seller in Q2 2015 was Millennium Management, an estimated $13.6M sold.
Based on aggregated 13F filings for Q2 2015.